



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Kinectin 1 Double Nickase Plasmid (h) | sc-404296-NIC | 20 µg | $410.00 | |||
Kinectin 1 Double Nickase Plasmid (h2) | sc-404296-NIC-2 | 20 µg | $410.00 |
KTN1 encodes kinectin 1, an integral membrane protein enriched on the endoplasmic reticulum that functions as a scaffold for microtubule-based transport. By interacting with kinesin motors and associated trafficking machinery, kinectin supports organelle positioning, ER dynamics, and directional movement of vesicles that influence secretion and membrane turnover. These processes intersect with cytoskeletal remodeling, intracellular signaling, and proteostasis pathways that are frequently perturbed under cellular stress conditions. Altered kinectin-dependent transport and ER organization have been examined in the context of neurobiology and other disorders where defects in axonal transport, membrane trafficking, or ER homeostasis contribute to disease-relevant phenotypes.
Kinectin 1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the KTN1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within KTN1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt KTN1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of KTN1-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.